Initial Experience With the AngioVac Venous Drainage Cannula - Trial NCT02775565
Access comprehensive clinical trial information for NCT02775565 through Pure Global AI's free database. This phase not specified trial is sponsored by Angiodynamics, Inc. and is currently Completed. The study focuses on Heart Disease. Target enrollment is 51 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Angiodynamics, Inc.
Timeline & Enrollment
N/A
Feb 01, 2016
May 01, 2017
Primary Outcome
Detailing early clinical experience with the AngioVac Venous Drainage Cannula
Summary
This is a retrospective, record-based study of approximately 100 patients across up to 12
 centers within the United States. All patients who have been treated with the AngioVac Venous
 Drainage Cannula and the Extracorporeal Circuit will be considered for study participation.
 Eligible subject must meet all of the inclusion criteria and none of the exclusion criteria
 to be considered enrolled in the study. The purpose of the study is to describe initial
 experience with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT02775565
Device Trial